IKZF1 and CDKN2A/B deletions are known to be associated with poor prognosis in pediatric and adult B-ALL populations27–29, mainly in the BCR-ABL1 B-ALL subpopulation. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.